Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canntab Therapeutics Limited C.TFS

"Canntab Therapeutics Ltd is a Canadian cannabis oral dosage formulation company based in Markham Ontario, engaged in the research and development of advanced pharmaceutical grade formulations of cannabinoids. It has developed in-house technology to deliver standardized medical cannabis extract from selective strains in a variety of extended/sustained release pharmaceutical dosages for therapeutic use."


CSE:TFS - Post by User

Comment by GajjarDron Jan 10, 2018 11:37am
88 Views
Post# 27323732

RE:Letter of Intent Clarification

RE:Letter of Intent ClarificationThank you, "Makeshift" for posting this clarification. All the bashers on this board probably lie in the 1000 lot bids at .05 cents which rarely has filled. This is the bottom how long it takes for the MJ investors to wake up is in times hands. GLTA
makeshift wrote:
Hi. Long time Stockhouse reader, only recently started an account to tune out some of the noise. I thought I would help clarify the LOI since the messages on this board are a bit all over the place.

Full disclosure, I own many shares in TFS.

I recently emailed TFS directly and received a very prompt response. I'm simply repeating what I've been told.

1. TFS shares will consolidate 200 to 1. So if the share price is 0.07 cents when it consolidates, you'll own 1 share worth $14.

2. Telferscot Resources will buy out Canntab shares at a rate of 4 TFS shares to 1 Canntab share. This has NOTHING to do with our TFS shares. It's how Telferscot is acquiring Canntab. Here, 1.6.1 is most likely correct about Canntab wanting to use TFS to go public. Read his/her post.

3. Canntab will raise $5 million by issuing 1,250,000 of their own shares much like a PP (possibly even a PP). The $4 price is set to attract investors and does not reflect the actual share price. It's usually set lower so investors will earn their money back. Again, this has nothing to do with our TFS shares but a condition of acquiring Canntab.

4. The 24.4 million shares resulting is a combination of the existing TFS shares (consolidated 200:1) and the acquired Canntab shares.

So at the current share price of 0.07 cents... is Canntab worth $14 a share and should their market cap be roughly $340 million? I look at other mj companies with a lot less going on... no license, facility under construction, etc. easily having market caps of $340 million+. Canntab has a definitive deal with Emblem (already licensed) and more.

GLTA


<< Previous
Bullboard Posts
Next >>